rs2254638: what the research says
A polymorphism identified as a predictive biomarker for clopidogrel response in a multi-gene NGS panel study.
What each genotype means
Potential clopidogrel response variation
Research has investigated the N6AMT1 rs2254638 polymorphism as a potential biomarker for clopidogrel response in specific patient populations. If you are prescribed clopidogrel, please discuss your medication management and any concerns about treatment response with your clinician or pharmacist.
The frequency of this genotype varies significantly across different global ancestral populations.
Potential clopidogrel response variation
Research has investigated the N6AMT1 rs2254638 polymorphism as a potential biomarker for clopidogrel response in specific patient populations. If you are prescribed clopidogrel, please discuss your medication management and any concerns about treatment response with your clinician or pharmacist.
The frequency of this genotype varies significantly across different global ancestral populations.
Potential clopidogrel response variation
Research has investigated the N6AMT1 rs2254638 polymorphism as a potential biomarker for clopidogrel response in specific patient populations. If you are prescribed clopidogrel, please discuss your medication management and any concerns about treatment response with your clinician or pharmacist.
The frequency of this genotype varies significantly across different global ancestral populations.
Variable
Curious what your genotype is for rs2254638?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
This variant is a significant risk factor for the development of Gaucher disease and Parkinson's disease.
This variant is associated with cystic fibrosis, affecting chloride channel function in epithelial cells.
This variant is a known pathogenic mutation contributing to hereditary breast and ovarian cancer syndrome.
This pathogenic variant is strongly associated with an increased lifetime risk of breast and ovarian cancer.
A variant significantly associated with clopidogrel responsiveness in diverse populations, highlighting the importance of transethnic genetic studies.
A sex-specific genetic locus on chromosome 11 associated with chronic pain in males.